{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:20:06Z","timestamp":1789122006312,"version":"build-2803163510"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematol. Rep.","Hematology Reports"],"abstract":"<jats:p>Background\/Objectives: Obesity and inflammatory conditions, including steatotic liver disease, are known to impact the hematopoietic niche and immune surveillance. Therefore, assessing the impact of steatotic liver disease on recipients of allogeneic stem cell transplantation (allo-HSCT) with bone marrow origin neoplasms is clinically relevant and an underexplored area of investigation. Methods: We followed the clinical course of allo-HSCT recipient patients with steatotic liver. Results: From 2014 to 2020 at our center, we identified 18 patients (5.8% of 306 patients screened) with steatotic liver disease detected on non-contrast CT imaging pre-transplant. With a minimum of 5 years follow-up for all, eight patients experienced post-transplant relapses (44%). Relapses (78%) followed by infections (55%) were the major contributors of mortality in this cohort. Pre-transplant transaminases were normal (AST median 28, ALT median 37) in all, while most patients (89%; 16\/18) developed abnormal transaminases in the first-year post-transplantation without evidence of permanent liver injury. None experienced veno-occlusive disease of the liver. The cumulative incidence of acute graft-versus-host disease (aGVHD) was 33% (6\/18), with 55% (10\/18) experiencing chronic graft-versus-host disease (cGVHD). Conclusions: Our descriptive study highlights that radiologically detected steatotic liver disease is not a contraindication to proceeding with allogeneic stem cell transplant, and its association with transaminitis, relapse, immune complications, and post-transplant metabolic health requires future mechanistic studies.<\/jats:p>","DOI":"10.3390\/hematolrep18050065","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:35:01Z","timestamp":1789061701000},"page":"65","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Steatotic Liver Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Case Series and Literature Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-1099","authenticated-orcid":false,"given":"Karthik","family":"Chetlapalli","sequence":"first","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Seropian","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-3162","authenticated-orcid":false,"given":"Francine","family":"Foss","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Isufi","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Perreault","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Pillai","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Zeidan","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahan","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noffar","family":"Bar","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kenworthy","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Israel","sequence":"additional","affiliation":[{"name":"Department of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohith","family":"Gowda","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.jhep.2023.08.019","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: Results from NHANES 2017-March 2020","volume":"80","author":"Luo","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2454707","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Singh, R., Rathore, S.S., Khan, H., Karale, S., Chawla, Y., Iqbal, K., Bhurwal, A., Tekin, A., Jain, N., and Mehra, I. (2022). Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.780872"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5114\/ceji.2018.77395","article-title":"Changes in the immune system\u2014The key to diagnostics and therapy of patients with non-alcoholic fatty liver disease","volume":"43","author":"Kosmalski","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Neumann, S., Campbell, K., Woodall, M.J., Evans, M., Clarkson, A.N., and Young, S.L. (2021). Obesity Has a Systemic Effect on Immune Cells in Naive and Cancer-Bearing Mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168803"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbmt.2008.10.029","article-title":"Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease","volume":"15","author":"Fuji","year":"2009","journal-title":"Biol. Blood Marrow. Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Paquissi, F.C. (2016). Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00490"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","article-title":"Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: How much progress has been made?","volume":"29","author":"Horan","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Maung, K., Ramalingam, S., Chaudhry, M., Ren, Y., Jung, S.H., Romero, K., Corbet, K., Chao, N.J., Choi, T., and Diehl, A.M. (2020). Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238824"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4930987","DOI":"10.1155\/2016\/4930987","article-title":"Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population","volume":"2016","author":"Wells","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow. Transpl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e12956","DOI":"10.1111\/sji.12956","article-title":"Cellular metabolism dictates T cell effector function in health and disease","volume":"92","author":"Kolan","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcmgh.2023.09.006","article-title":"IFNgamma and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in Mice","volume":"17","author":"Krzikalla","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104195","DOI":"10.1016\/j.cellimm.2020.104195","article-title":"The hepatic microenvironment and regulatory T cells","volume":"357","author":"Bozward","year":"2020","journal-title":"Cell. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41409-023-02154-6","article-title":"The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: A study from the EBMT Transplant Complications Working Party","volume":"59","author":"Gjaerde","year":"2024","journal-title":"Bone Marrow Transpl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10753-012-9533-7","article-title":"Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease","volume":"36","author":"Gebremedhin","year":"2013","journal-title":"Inflammation"},{"key":"ref_24","first-page":"417.e1","article-title":"Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes","volume":"30","author":"Rashid","year":"2024","journal-title":"Transpl. Cell. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ltac015","DOI":"10.1093\/immadv\/ltac015","article-title":"Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy","volume":"2","author":"Machado","year":"2022","journal-title":"Immunother. Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: Dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Anagnostopoulos","year":"2004","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1073\/pnas.1514511113","article-title":"Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution","volume":"113","author":"Youm","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep4.1304","article-title":"Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma","volume":"3","author":"Alao","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jcyt.2024.07.002","article-title":"Chronic liver disease after allogeneic hematopoietic cell transplantation","volume":"26","author":"Randhawa","year":"2024","journal-title":"Cytotherapy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbmt.2019.02.001","article-title":"New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications","volume":"25","author":"Engelhardt","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1038\/s41467-019-13498-3","article-title":"Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites","volume":"10","author":"Michonneau","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.114.218099","article-title":"Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease","volume":"351","author":"Glick","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e55747","DOI":"10.15252\/embr.202255747","article-title":"Metabolomics meets systems immunology","volume":"24","author":"Fu","year":"2023","journal-title":"EMBO Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Furuta, K., Guo, Q., Hirsova, P., and Ibrahim, S.H. (2020). Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis. Biology, 9.","DOI":"10.3390\/biology9110395"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2014.03.047","article-title":"Inherited disorders of bilirubin transport and conjugation: New insights into molecular mechanisms and consequences","volume":"146","author":"Erlinger","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1525-1594.1996.tb00652.x","article-title":"Veno-occlusive disease of the liver following bone marrow transplantation: A clinical-pathological study of autopsy cases","volume":"20","author":"Watanabe","year":"1996","journal-title":"Artif. Organs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: Pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3748\/wjg.v20.i37.13306","article-title":"Nonalcoholic fatty liver disease and vascular disease: State-of-the-art","volume":"20","author":"Fargion","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese Fatty Liver Disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e241171","DOI":"10.1148\/radiol.241171","article-title":"Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis","volume":"313","author":"Haghshomar","year":"2024","journal-title":"Radiology"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/5\/65\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:16:31Z","timestamp":1789118191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/5\/65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["hematolrep18050065"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep18050065","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}